Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 1, 2011, Pages 23-28

  Pais, R ^a   Pascale, A ^a   Fedchuck, L ^a   Charlotte, F ^a   Poynard, T ^a   Ratziu, V ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MALE; METABOLIC SYNDROME X; MONITORING; NONALCOHOLIC FATTY LIVER; RISK FACTOR; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79956011925     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.06.004     Document Type: Article

References (15)

1. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43(2 Suppl. 1):S99-S112.
2. Argo C.K., Northup P.G., Al-Osaimi A.M., Caldwell S.H. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009, 51(2):371-379.
3. Soderberg C., Stal P., Askling J., Glaumann H., Lindberg G., Marmur J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
4. Adams L.A., Lymp J.F., St Sauver J., Sanderson S.O., Lindor K.D., Feldstein A., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129(1):113-121.
5. Ekstedt M., Franzen L.E., Mathiesen U.L., Thorelius L., Holmqvist M., Bodemar G., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44(4):865-873.
6. Harrison S.A., Torgerson S., Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003, 98(9):2042-2047.
7. Kim S.R., Nakajima T., Ando K., Mita K., Fukuda K. Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver. J Gastrointestin Liver Dis 2009, 18(4):491-495.
8. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41(6):1313-1321.
9. Ratziu V., Charlotte F., Heurtier A., Gombert S., Giral P., Bruckert E., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005, 128(7):1898-1906.
10. Merriman R.B., Ferrell L.D., Patti M.G., Weston S.R., Pabst M.S., Aouizerat B.E., et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006, 44(4):874-880.
11. Hamaguchi M., Kojima T., Takeda N., Nakagawa T., Taniguchi H., Fujii K., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143(10):722-728.
12. Malhi H., Gores G.J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008, 28(4):360-369.
13. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37(4):917-923.
14. Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46(4):1081-1090.
15. Li Z.Z., Berk M., McIntyre T.M., Feldstein A.E. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 2009, 284(9):5637-5644.